Source comparison
Complete comparison: sermorelin vs GLP-1 medications
Peptide class GHRH analog GLP-1R / GIP dual agonist GLP-1R / GIP / glucagon triple agonist Target receptor GHRH-R on pituitary GLP-1R in gut, brain, pancreas GLP-1R + GIPR GLP-1R + GIPR + glucagon-R Primary indication GH deficiency (off-label adult) Obesity, t
This comparison does not assign a generated winner or score.
- Peptide class
- GHRH analog
- GLP-1R / GIP dual agonist
- GLP-1R / GIP / glucagon triple agonist
- Target receptor
- GHRH-R on pituitary
- GLP-1R in gut, brain, pancreas
- GLP-1R + GIPR
- GLP-1R + GIPR + glucagon-R
- Primary indication
- GH deficiency (off-label adult)
- Obesity, type 2 diabetes
- Obesity (phase 3)
- Weight loss magnitude
- 2-5% (recomposition)
- ~24%
- Muscle impact
- Positive (promotes lean mass)
- Negative (39% of loss is lean)
- Moderately negative
- Under study (concern exists)
- Appetite suppression
- None directly
- Strong
- Very strong
- Dosing schedule
- Daily subcutaneous injection
- Weekly subcutaneous injection
- Dose range
- 200-500mcg/day
- 0.25mg to 2.4mg/week
- 2.5mg to 15mg/week
- 0.5mg to 12mg/week (protocol-dependent)
- Main side effects
- Injection site reaction, headache
- Nausea, vomiting, constipation
- GH axis impact
- Raises GH and IGF-1
- None
- Blood glucose effect
- Mild improvement via IGF-1
- Strong glycemic control
- Strongest glycemic control
- FDA approved for adults
- No (compounding pharmacies)
- Yes (Ozempic, Wegovy)
- Yes (Mounjaro, Zepbound)
- No (phase 3 trials)
- Combination potential
- Combines well with GLP-1
- Can combine with sermorelin
- Combination data limited
- Best for
- GH deficiency, aging, muscle, mild fat loss
- Significant weight loss, T2D
- Maximum weight loss, T2D
- Maximum weight loss (experimental)
- This table represents the clearest single-view comparison available. Use it to orient the decision, not to make it. The right choice depends on factors beyond any table: your current health status, your lab values, your goals, your physician guidance, and your personal tolerance for different side effect profiles. SeekPeptides members access detailed protocol comparisons, evidence summaries, and member experiences that go beyond what any general guide can offer.